Abstract
Ovarian cancer resistance to available medicines is a huge challenge in dire need of a solution, which makes its recurrence and mortality rate further exacerbated. A promising approach to overcome chemoresistance is drug screening from natural products. Here, we report that NK007, a (±)-tylophorine malate isolated from the Asclepiadaceae family, selectively inhibited the proliferation of A2780 and A2780 (Taxol) cells and migration of paclitaxel-sensitive and -resistant ovarian cancer cells. Interestingly, the decline of cell viability, including cell multiplication, clonality, and migration capacity was independent on cell apoptosis. At the molecular level, NK007 considerably induced G1/S arrest and upregulated the expression of phospho-p38 mitogen-activated protein kinase (p-p38MAPK). In addition, hexokinase 2 (HK2) protein degradation was considerably elevated in the presence of NK007, which resulted in the reduction of oxygen consumption rate and extracellular acidification rate. Altogether, our results indicate that NK007, an analog of tylophorine, can overcome paclitaxel (PTX) resistance through p38MAPK activation and HK2 degradation. As an effective, alternative antiresistance agent, NK007 exhibits a promising potential t...Continue Reading
References
Apr 29, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J S BerekP H Willemse
Nov 7, 1999·Journal of Molecular Evolution·D R CaffreyD C Shields
May 3, 2001·Nature·D V BulavinA J Fornace
Feb 21, 2004·Journal of Animal Science·M ObaB J Bequette
Feb 17, 2007·The EMBO Journal·Eusebio PerdigueroPura Muñoz-Cánoves
Sep 20, 2007·Expert Opinion on Drug Safety·Neena I MarupudiHenry Brem
Jan 23, 2009·International Journal of Biological Sciences·Tina M Thornton, Mercedes Rincon
Jul 30, 2009·Cancer Research·Chioniso Patience Masamha, Doris Mangiaracina Benbrook
Sep 3, 2009·Molecular Cancer Research : MCR·Diane PalmieriPatricia S Steeg
Oct 15, 2009·Oncogene·M SzajnikT L Whiteside
Dec 17, 2009·Journal of Agricultural and Food Chemistry·Kailiang WangQingmin Wang
Dec 19, 2009·The Journal of Biological Chemistry·Yongjun FanWei-Xing Zong
May 12, 2012·Arthritis and Rheumatism·Ti WenZhinan Yin
Aug 30, 2012·International Immunopharmacology·Ti WenZhinan Yin
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Parisa Fathi RezaeiEbrahim Azizi
Jul 13, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Katrina F TriversJuan L Rodriguez
Aug 6, 2013·Cancer Cell·Krushna C PatraNissim Hay
Oct 15, 2013·Cancer Discovery·Susana Ros, Almut Schulze
Feb 25, 2014·Advances in Experimental Medicine and Biology·Brian K Kennedy, Juniper K Pennypacker
Mar 4, 2014·Gynecologic Oncology·K StålbergH Kieler
May 3, 2014·Journal of Neuro-oncology·Shabnam PakneshanBahman Jabbari
Jun 6, 2014·Journal of Immunology Research·Glauben LandskronMarcela A Hermoso
Aug 27, 2014·Gynecologic Oncology·Britton TrabertNicolas Wentzensen
Oct 18, 2014·Cell Death and Differentiation·D J Roberts, S Miyamoto
Jun 16, 2015·Autophagy·Valerie P Tan, Shigeki Miyamoto
Sep 2, 2015·The Journal of Cell Biology·Hong-Guang XiaHelin Vakifahmetoglu-Norberg
Nov 17, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yanyan MaXiaoyan Wang
Feb 18, 2016·British Journal of Cancer·Brittney S HarringtonJohn D Hooper
Feb 15, 2017·American Journal of Reproductive Immunology : AJRI·Elizabeth A Bonney
Apr 22, 2017·Cell Death and Differentiation·Kaori KanemaruKiyoko Fukami
Jun 14, 2017·Nature·Haizhen WangPiotr Sicinski
Oct 6, 2017·Autophagy·Lin JiaoXiao-Feng Zhu
Apr 26, 2018·Nature Reviews. Cancer·Frederick A DickNicholas J Dyson